India Artificial Cornea and Corneal Implant Market

India Artificial Cornea and Corneal Implant Market Overview:

The India artificial cornea and corneal implant market size reached USD 42.20 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 73.50 Million by 2033, exhibiting a growth rate (CAGR) of 5.70% during 2025-2033. The market is driven by the rising prevalence of corneal blindness, favorable government support and technological advancements.

India Artificial Cornea and Corneal Implant Market Trends:

Rising Prevalence of Corneal Blindness

India is witnessing a growing burden of corneal blindness, primarily due to infections, injuries, and congenital conditions. According to the National Programme for Control of Blindness and Visual Impairment (NPCBVI), corneal diseases are among the leading causes of blindness in the country, with an increasing number of patients requiring corneal transplants. For instance, in 2024, as per industry reports, corneal blindness is increasing in India, with 20,000-25,000 new cases annually, especially in rural areas, where limited healthcare access and donor shortages hinder treatment, exacerbating vision loss across affected populations. However, donor corneas continue to remain insufficient in supply for the ever-increasing demand. This has widened the scope for the use of artificial corneas as viable alternatives for donor corneal transplantation. Various companies and research institutions are concentrating on the development of biocompatible corneal substitutes with a minimum risk of rejection and better long-term outcomes for the patients. Government schemes and partnerships with global eye banks to strengthen the supply chain and improve access to corneal implants in India is further driving the market growth.

Government Support and Technological Advancements Driving Market Expansion

The market is further supported by robust government initiatives to enhance the national transplant ecosystem. The upcoming launch of a centralized platform by the National Organ and Tissue Transplant Organisation (NOTTO) aims to streamline the cornea transplant process by integrating data on waiting lists, donations, transplant procedures, and tissue utilization across hospitals and eye banks nationwide. This move is expected to improve transparency, coordination, and efficiency—critical factors in addressing India’s significant corneal tissue shortage. In parallel, India is witnessing pioneering efforts in logistics innovation, with successful trials of drone-based transportation for human corneas and amniotic grafts. Conducted by ICMR, these trials demonstrated a drastic reduction in delivery time from over two hours by road to just 40 minutes by air—ensuring timely access to transplant-ready tissues. These advancements will optimize the existing supply chain while reducing the burden on major hospitals.

India Artificial Cornea and Corneal Implant Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the region level for 2025-2033. Our report has categorized the market based on type, transplant type, disease indication, and end user.

Type Insights:

• Human Cornea
• Artificial Cornea

The report has provided a detailed breakup and analysis of the market based on the type. This includes human cornea and artificial cornea.

Transplant Type Insights:

• Penetrating Keratoplasty
• Endothelial Keratoplasty
• Anterior Lamellar Keratoplasty
• Keratoprosthesis

A detailed breakup and analysis of the market based on the transplant type have also been provided in the report. This includes penetrating keratoplasty, endothelial keratoplasty, anterior lamellar keratoplasty, and keratoprosthesis.

Disease Indication Insights:

• Fuchs' Dystrophy
• Fungal Keratitis
• Keratoconus
• Others

A detailed breakup and analysis of the market based on the disease indication have also been provided in the report. This includes Fuchs' dystrophy, fungal keratitis, keratoconus, and others.

End User Insights:

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics

A detailed breakup and analysis of the market based on the end user have also been provided in the report. This includes hospitals, ambulatory surgical centers, and specialty clinics.

Regional Insights:

• North India
• South India
• East India
• West India

The report has also provided a comprehensive analysis of all the major regional markets, which include North India, South India, East India, and West India.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

India Artificial Cornea and Corneal Implant Market News:

• In March 2025, L V Prasad Eye Institute (LVPEI) announced securing of an Australian patent for a novel cell therapy using limbal epithelial and stromal cells to treat corneal diseases. Developed by Dr Sayan Basu and Dr Vivek Singh, this therapy offers a transplant alternative, utilizing autologous or donor corneal stem cells for regeneration.
• In September 2024, Centre for Sight, an Indian ophthalmology network, partnered with Mumbai's Laxmi Eye Hospital, marking its 9th center in Maharashtra. Over the past year, Centre for Sight invested Rs 300 crore to establish 13 new centers across India, bringing its total to 82, and plans to open 12 more centers with an additional investment of around Rs 300 crore in the coming year. The company's expansion strategy includes both strategic collaborations and greenfield ventures, with the goal of increasing the total number of centers to 150 over the next four years.

India Artificial Cornea and Corneal Implant Market Report Coverage:

Key Questions Answered in This Report:

• How has the India artificial cornea and corneal implant market performed so far and how will it perform in the coming years?
• What is the breakup of the India artificial cornea and corneal implant market on the basis of type?
• What is the breakup of the India artificial cornea and corneal implant market on the basis of transplant type?
• What is the breakup of the India artificial cornea and corneal implant market on the basis of disease indication?
• What is the breakup of the India artificial cornea and corneal implant market on the basis of end user?
• What is the breakup of the India artificial cornea and corneal implant market on the basis of region?
• What are the various stages in the value chain of the India artificial cornea and corneal implant market? 
• What are the key driving factors and challenges in the India artificial cornea and corneal implant?
• What is the structure of the India artificial cornea and corneal implant market and who are the key players?
• What is the degree of competition in the India artificial cornea and corneal implant market? 

Key Benefits for Stakeholders:

• IMARC’s industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the India artificial cornea and corneal implant market from 2019-2033.
• The research report provides the latest information on the market drivers, challenges, and opportunities in the India artificial cornea and corneal implant market.
• Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the India artificial cornea and corneal implant industry and its attractiveness.
• Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.